CARCINOMA IN SITU
Clinical trials for CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to keep bladder cancer from coming back
Disease control Recruiting nowThis study tests whether adding the experimental drug V940 to standard BCG immunotherapy helps people with high-risk non-muscle invasive bladder cancer live longer without their cancer returning or spreading. About 308 adults whose bladder cancer has not invaded the muscle will b…
Matched conditions: CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New tumor injection shows promise for advanced cancers
Disease control Recruiting nowThis early-stage trial tests a new drug, ONM-501, injected directly into tumors, either alone or with another drug (cemiplimab), for people with advanced solid tumors or lymphomas that have not responded to other treatments. The study aims to find the safest dose and check for si…
Matched conditions: CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Massive cancer registry aims to unlock better treatments for kids
Knowledge-focused Recruiting nowThis study is a large registry for children and young adults with cancer. It collects health information and leftover tumor or blood samples over time. The goal is to help doctors find better ways to treat and care for these patients. Up to 75,000 people will take part.
Matched conditions: CARCINOMA IN SITU
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 16, 2026 23:45 UTC